GlaxoSmithKline S.A.E. (BIOC) Key Statistics
26 reported figures for GlaxoSmithKline S.A.E. — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 21.57B
- P/E (trailing)
- 633.72
- P/B
- 9.89
- Dividend yield (FY 2018)
- 0.19%
Income (latest fiscal year)
- Revenue
- EGP 1.62B
- Net income
- EGP 49.92M
- EBITDA
- EGP 139.12M
- Free cash flow
- EGP 182.31M
- Profit margin
- 3.08%
Balance sheet
- Total assets
- EGP 2.04B
- Total debt
- EGP 1.75B
- Book value
- EGP 2.18B
Growth
- Revenue growth
- 11.69%
- Profit growth
- -56.65%
- EPS growth
- -66.75%
Per share
- EPS (fiscal year)
- 0.41
- Book value per share
- 26.12
- Dividend per share
- 0.5
- Return on equity
- 4.69%
- Return on assets
- 2.52%
Technical
- RSI (14)
- 43.6
- 50-day moving average
- EGP 322.3
- 200-day moving average
- EGP 154.88
- Beta (1Y)
- 0.6
Shares
- Shares outstanding
- 83.51M
- Free float
- 2.91%
Fiscal-year figures are as the company last reported them; technical readings refresh with market data.